Search Results - "Dreyfuss, A."

UPFRONT RADIATION THERAPY FOR POST‐STEM CELL TRANSPLANT MULTIPLE MYELOMA PATIENTS WITH OLIGO‐RELAPSE/PROGRESSIVE DISEASE: FACTORS ASSOCIATED WITH FAVORABLE OUTCOMES by Fregonese, B., Dreyfuss, A., Imber, B., Yahalom, J., Hajj, C.

Get full text

Radiotherapy as an effective bridge for chemo‐refractory or progressive secondary CNS lymphoma by Cederquist, G., Tringale, K., Hajj, C., Hubbeling, H., Sarkar, R., Ma, J., Dreyfuss, A., Fregonese, B., Lee, J., Salles, G., Scordo, M., Grommes, C., Falchi, L., Yahalom, J., Imber, B.

Get full text

Radiation in a new era of Multiple Myeloma management: Patterns of utilization, clinical, radiologic, and biochemical outcomes, and possible genomic correlates of response by Dreyfuss, A. D., Fregonese, B., Ma, J., Reith, S., Cederquist, G., Hubbeling, H., Tringale, K. R., Wijetunga, N A., Usmani, S., Hajj, C., Imber, B. S., Yahalom, J.

Get full text

Docetaxel: an active drug for squamous cell carcinoma of the head and neck by Dreyfuss, A I, Clark, J R, Norris, C M, Rossi, R M, Lucarini, J W, Busse, P M, Poulin, M D, Thornhill, L, Costello, R, Posner, M R

“…We conducted a phase II study designed to evaluate the activity, safety, and tolerability of docetaxel (Taxotere: Rhône-Poulenc Rorer Pharmaceuticals Inc,…”
Get more information

Getting past the first year: Retaining engineering majors by Dreyfuss, A. E., Villatoro, Melanie, Loui, Michael C., Becvar, James E., Saupe, Geoffrey B., Johnson, Wayne

“…Peer Led Team Learning (PLTL) is a nationally recognized curriculum enhancement strategy adopted in various forms by over 150 universities and colleges across…”
Get full text

Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial by Colevas, A D, Busse, P M, Norris, C M, Fried, M, Tishler, R B, Poulin, M, Fabian, R L, Fitzgerald, T J, Dreyfuss, A, Peters, E S, Adak, S, Costello, R, Barton, J J, Posner, M R

“…A phase I/II trial of docetaxel, cisplatin, fluorouracil (5-FU), and leucovorin (TPFL5) induction chemotherapy for patients with locally advanced squamous cell…”
Get more information

Radiation Therapy for Oligo-Relapsed/Progressive Disease Post-Stem Cell Transplant for Multiple Myeloma: Factors Associated with Favorable Outcomes by Fregonese, B., Dreyfuss, A., Usmani, S., Imber, B.S., Yahalom, J.

“…Relapsed or refractory Multiple Myeloma (MM) following stem cell transplant (SCT) poses significant clinical challenges. Localized relapse or progression…”
Get full text

Prospective Evaluation of MRI-Based Endoluminal Brachytherapy with Novel Applicator for Anorectal Cancer by Dreyfuss, A., Cohen, G.N., Weiser, M., Goodman, K.A., Wu, A.J.

“…To present results of patients treated on a prospective dose escalation trial of MRI-based endoluminal high dose rate (HDR) brachytherapy (BT) and concurrent…”
Get full text

Early Experience with Salvage RT for Relapsed / Refractory Multiple Myeloma Following BCMA-Directed CAR T Cell Therapy by Dreyfuss, A., Fregonese, B., Mailankody, S., Usmani, S., Imber, B.S., Yahalom, J.

“…Despite impressive response rates, relapse after chimeric antigen T cell receptor therapy (CART) for Multiple Myeloma (MM) is common, potentiating the need for…”
Get full text

Radiation Therapy (RT) in a New Era of Multiple Myeloma (MM) Therapy: Trends of Engagement and Radiologic, Biochemical, and Cytogenetic Correlates of Outcomes and Response by Dreyfuss, A., Fregonese, B., Cederquist, G., Usmani, S., Imber, B.S., Yahalom, J.

“…Systemic therapies for MM have advanced considerably. Yet, the use of RT has remained stagnant due to heterogeneous integration into modern treatments. Here we…”
Get full text

Failure Patterns by PET for Relapsed / Refractory Multiple Myeloma (r/r MM) after CAR T Cell Therapy: Potential Role for Radiotherapy (RT)? by Dreyfuss, A., Fregonese, B., Hubbeling, H.G., Mailankody, S., Usmani, S., Yahalom, J., Imber, B.S.

“…Chimeric antigen T cell receptor therapy (CART) offers impressive response rates in MM. However, a significant proportion of patients still relapse or remain…”
Get full text

The Use of 18F-fluciclovine PET/CT in Prostate Cancer Diagnosis and Therapeutic Decision Making by Dreyfuss, A., Ahn, G.S., Barsky, A.R., Pantel, A.R., Vapiwala, N.

Get full text

Exploring the Phenomenon of Leading through the Experiences of Peer Leaders by Dreyfuss, A. E

“…The concept of leadership has been explored in many contexts, yet it is not a role that is expected as part of a college education. "Peer Leaders" are in a…”
Get full text

Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results by Clark, J R, Busse, P M, Norris, Jr, C M, Andersen, J W, Dreyfuss, A I, Rossi, R M, Poulin, M D, Colevas, A D, Tishler, R B, Costello, R, Lucarini, J W, Lucarini, D, Thornhill, L, Lackey, M, Peters, E, Posner, M R

“…A phase II trial of cisplatin, fluorouracil, and leucovorin (PFL) induction chemotherapy in patients with locally advanced squamous cell carcinomas of the head…”
Get more information

Patterns of Intracranial Response and Relapse after Radiotherapy for Patients with Chemorefractory or Progressive Secondary CNS Lymphoma by Cederquist, G., Tringale, K.R., Hajj, C., Moore, Z.R., Hubbeling, H.G., Dreyfuss, A., Fregonese, B., Falchi, L., Scordo, M., Grommes, C., Yahalom, J., Imber, B.S.

“…Progressive secondary CNS lymphoma (SCNSL) after failure of CNS-directed systemic therapy is a challenging clinical entity with limited treatment options…”
Get full text

Dose Response of Bulky Tumors in Relapsed/Refractory Diffuse Large B-Cell Lymphoma by Maxwell, R.J.L., Wright, C.M., Baron, J., Dreyfuss, A., LaRiviere, M.J., Chong, E.A., Maity, A., Plastaras, J.P., Paydar, I.

Get full text

Locoregional Control Benefit of a Tumor Bed Boost for Ductal Carcinoma In Situ (DCIS) by Dreyfuss, A., Max, D., Flynn, J., Zhang, Z., Gillespie, E.F., Xu, A.J., Cuaron, J., Mueller, B.A., Khan, A.J., Cahlon, O., Powell, S.N., McCormick, B., Braunstein, L.Z.

“…Radiotherapy (RT) following breast conserving surgery (BCS) for ductal carcinoma in situ (DCIS) reduces invasive and in situ recurrences. Whereas landmark…”
Get full text

Radiation in a New Era of Multiple Myeloma Management: Patterns of Utilization, Clinical, Radiologic, and Biochemical Outcomes, and Possible Genomic Correlates of Response by Dreyfuss, A., Fregonese, B., Ma, J., Sarkar, R.R., Lee, J., Cederquist, G., Hubbeling, H.G., Tringale, K.R., Wijetunga, N.A., Usmani, S., Hajj, C., Imber, B.S., Yahalom, J.

“…Systemic therapies for multiple myeloma (MM) have advanced considerably, improving patient outcomes. Yet, the use of radiotherapy (RT) has remained…”
Get full text

Alpha clustering and alpha-capture reaction rate from ab initio symmetry-adapted description of $^{20}$Ne by Dreyfuss, A. C, Launey, K. D, Escher, J. E, Sargsyan, G. H, Baker, R. B, Dytrych, T, Draayer, J. P

“…Phys. Rev. C 102, 044608 (2020) We introduce a new framework for studying clustering and for calculating alpha partial widths using ab initio wave functions…”
Get full text

A Novel Mouse Model to Study Image-Guided, Radiation-Induced Cardiac Injury and Identify Clinically Relevant Predictors of Toxicity by Dreyfuss, A., Verginadis, I., Shoniyozov, K., Velapoulou, A., Goia, D., Bravo, P., Feigenberg, S.J., Ky, B., Koumenis, C.

Get full text